Actinium Pharmaceuticals, Inc. (ATNM)

1.50 +0.05 (+3.45%) USD  |  NYAM  |  Dec 12, 10:46
More

Actinium Pharmaceuticals Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Arcus Biosciences, Inc. Upgrade
Apyx Medical Corp. Upgrade
AbbVie, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade